SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around the upcoming 4/20 cultural event and its mission to champion global cannabis legalization, frequently proclaiming itself "like Bitcoin but way higher" as it builds a long-term "culture coin" on Solana.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is trending due to new exchange listings, expanded utility like Solana integration, and its AI agent capabilities on the Base ecosystem, driving community speculation for a significant price surge amidst ongoing "pump and dump" concerns.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is trending as the community rallies around its status as Solana's privacy layer, touting its recent Solflare and Zebec integrations, low market cap, and ability to show strength in a fluctuating market, with many seeing it as a high-potential utility play with upcoming revenue share.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as regulatory bodies signal swift action against unauthorized compounded GLP-1 weight-loss drugs, prompting widespread community discussion about how this bolsters NVO's market position and intellectual property, potentially mitigating concerns from its recent conservative outlook.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to significant volatility following its decision to discontinue a compounded oral GLP-1 weight-loss pill, which stemmed from increased FDA scrutiny and legal threats from Novo Nordisk. Community discussion is sharply divided between those predicting further declines due to management's perceived missteps and others who see it as a strategic move to remove regulatory overhang, highlighting the company's broader telehealth offerings and potential for a short squeeze.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending following its recent earnings, which highlighted robust user and revenue growth alongside management's commitment to substantial share buybacks; however, community discussion is polarized by concerns over its immediate profitability metrics and the evolving landscape of autonomous vehicle competition.

The AES Corp. engages in the provision of power generation and utility services through its renewable and thermal generation facilities and distribution businesses. It operates through the following segments: U.S. and Utilities Strategic Business Unit (SBU), South America SBU, MCAC SBU, Eurasia SBU. The U.S. and Utilities SBU segment consists of facilities in the United States, Puerto Rico and El Salvador. The South America SBU segment covers Chile, Colombia, Argentina, and Brazil. The MCAC SBU segment refers to Mexico, Central America, and the Caribbean. The Eurasia SBU segment handles operations in Europe and Asia. The company was founded by Dennis W. Bakke and Roger W. Sant in 1981 and is headquartered in Arlington, VA.

AES Corp.

AES is actively trending amid speculation that BlackRock's Global Infrastructure Partners is nearing a takeover, with community discussions largely centered on the company's attractive position in supplying energy for the rapidly expanding AI and data center industries, juxtaposed with debates over the appropriate acquisition premium given its substantial debt load.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending following its FreeNow acquisition, expanding its European market presence, and strategic partnerships with Waymo and Baidu for autonomous vehicle integration. The community actively debates the long-term impact of robotaxis on its business model, with many speculating about Lyft's potential as an acquisition target.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending due to anticipation of accelerated growth in its upcoming Q4 earnings and seasonally strong Q1, coupled with new partnerships like Kikoff and potential deep integration with Hyundai Secure+. The community actively discusses its significant undervaluation, strong AI-driven fundamentals, and high short interest despite recent market pressure, signaling potential for a substantial rebound or even a buyout.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt Holdings is actively discussed as a potential core infrastructure provider for NYSE's newly announced tokenized trading platform. Investors are closely watching how this opportunity balances against ongoing concerns about share dilution and volatile Bitcoin price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KOD Stock Up 24% in 3 Months: Here's What You Need to Know

Kodiak Sciences' shares jump 24% in three months as late-stage retinal programs advance and fresh funding extends its cash runway, fueling investor confidence.

Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results

VSTM shares rise nearly 8% after the release of preliminary fourth-quarter 2025 and full-year 2025 sales numbers, driven by Avmapki Fakzynja Co-pack.

FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to Datroway

AstraZeneca wins FDA priority review for Datroway in triple-negative breast cancer, while Saphnelo SC receives a complete response letter.

Sanofi's Venglustat Meets Primary Endpoints in Gaucher Disease Study

SNY's phase III LEAP2MONO study meets all primary endpoints, with venglustat improving neurological symptoms in type 3 Gaucher disease patients.

Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength?

Harrow (HROW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome 

RARE resubmits FDA filing for UX111 after CRL, adding long-term neurologic and biomarker data, with a Q3 2026 decision in sight.

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 230.6% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug 

Summit Therapeutics' ivonescimab BLA wins FDA acceptance for EGFR-mutated NSCLC, with a PDUFA action date of Nov. 14, 2026.

Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year?

Here is how ADC Therapeutics SA (ADCT) and Assertio (ASRT) have performed compared to their sector so far this year.

Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet

The consensus price target hints at a 249.9% upside potential for Assertio (ASRT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$3.12	--	--	N/A
Q3 '25	-$0.09	$1.65	2041.18%	BEAT
Q2 '25	-$0.09	-$0.17	-88.89%	MISSED
Q1 '25	-$0.06	-$0.14	-133.33%	MISSED
Q4 '24	-$0.04	-$0.11	-150.00%	MISSED

ASRT
Assertio Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ASRT News

ASRTAssertio Holdings Inc